ABCL-022 Pharmacokinetics and Pharmacodynamics in First-MIND: A Phase Ib, Open-Label, Randomized Study of Tafasitamab ± Lenalidomide + R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Clinical Lymphoma Myeloma and Leukemia（2022）
摘要
MorphoSys AG.
更多查看译文
关键词
ABCL,tafasitamab,lenalidomide,DLBCL,First-MIND,pharmacokinetics,Phase I
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要